Role of Alveolar Macrophages in Rapid Elimination of Adenovirus Vectors Administered to the Epithelial Surface of the Respiratory Tract
- 20 September 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (14) , 1675-1684
- https://doi.org/10.1089/hum.1997.8.14-1675
Abstract
To evaluate the hypothesis that innate immune mechanisms play a major role in eliminating adenovirus (Ad) vectors from the lung, the fate of adenoviral genome of an Ad vector was quantified in the first 24 h after intratracheal administration of an Ad vector coding for β-galactosidase (βgal) to mice. Southern analysis with an Ad specific probe showed that 70% of the Ad genome was lost within 24 h, in both immunocompetent and immunodeficient animals. When alveolar macrophages were eliminated by administration of liposomes containing dichloromethylene-biphosphanate, subsequent administration of Ad vector was associated with a 100% ± 8% increase in lung Ad DNA and 96% ± 9% rise in βgal expression at 24 h compared to control animals. In vitro infection of mouse, rat, and human alveolar macrophages with an Ad vector resulted in 65% loss of vector genome within 24 h, whereas the vector genome was stable in lung epithelial cell lines. PCR in situ hybridization demonstrated that the Ad vector genome persisted A549 lung epithelial cell in vitro but not in alveolar macrophages. Finally, alveolar macrophages recovered from the mouse lung 30 min following intratracheal administration of an Ad vector showed large amounts of vector genome, whereas much less was evident in alveolar macrophages recovered after 24 h. These observations demonstrate that alveolar macrophages play an important role in elimination of Ad vectors from the lung and suggest that strategies to transiently suppress this major innate immune defense system might be rewarding in enhancing the efficiency Ad vectors for lung gene therapy. Antiviral host defense mechanisms are being held responsible for the loss of adenoviral vectors over time. The present study emphasizes the innate immune clearance of adenoviral vectors administered to the respiratory tract and elucidates the role of alveolar macrophages in the rapid loss of vector genome.Keywords
This publication has 33 references indexed in Scilit:
- Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivoGene Therapy, 1997
- Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors FollowingIn VivoAdministrationHuman Gene Therapy, 1997
- Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administrationNature Genetics, 1995
- Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosisNature Genetics, 1994
- Efficient Adenovirus-Mediated Gene Transfer into Human Blood Monocyte-Derived MacrophagesBiochemical and Biophysical Research Communications, 1993
- In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epitheliumCell, 1992
- Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice.The Journal of Experimental Medicine, 1989
- The murine cellular immune response to adenovirus type 5Immunology & Cell Biology, 1989
- Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80.The Journal of Experimental Medicine, 1985
- Natural killer cells are present in the normal human lung but are functionally impotent.Journal of Clinical Investigation, 1984